Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-50.44%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-50.44%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-275.74%
20%
—
—
20%
—
5 Years
Score—
Net Growth-275.74%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Unicycive Therapeutics Inc fundamental performance
Across Unicycive Therapeutics Inc's full reported history, from 2018 to 2025, net income went from -$ 1M to -$ 26M. Revenue increased in 14% of the years measured; net income in 13%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 5.39 | — |
1 Year2025-08-12 | $ 4.25 | 26.82% |
5 Years2021-08-12 | $ 28.00 | -80.75% |
All Time2021-07-12 | $ 50.00 | -89.22% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-12 |
|---|---|---|---|---|
| Price | $ 5.39 | $ 4.25 | $ 28.00 | $ 50.00 |
| Return | — | 26.82% | -80.75% | -89.22% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 39M | $ 54M |
| 2025 | $ 0.00 | -$ 26M | $ 41M |
| 2024 | $ 0.00 | -$ 36M | $ 26M |
| 2023 | $ 675K | -$ 30M | $ 9M |
| 2022 | $ 951K | -$ 18M | $ 455K |
| IPO2021 | $ 0.00 | -$ 10M | $ 16M |
| 2020 | $ 0.00 | -$ 2M | |
| 2019 | $ 0.00 | -$ 2M | $ 15K |
| 2018 | -$ 1M | $ 25K |
Explore beyond UNCY
You're looking at Unicycive Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
